[Influence of high mobility group box 1 on migration of human cord blood CD34(+) cells]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):422-5.
[Article in Chinese]

Abstract

The objective of study was to explore the influence of high mobility group box 1 (HMGB1) on migration of cord blood CD34(+) cells and their mechanism of migration. The expressions of receptor for advanced glycation end products (RAGE), toll-like receptor-2 (TLR2) and TLR4 were detected by flow cytometry. The CD34(+) cells in umbilical cord blood (CB) were enriched by MiniMACS and were exposed to various concentration of HMGB1 (10, 50, 100, 1, 000 ng/ml), then the migration effect of HMGB1 on umbilical cord blood (UCB) CD34(+) cell count was determined by microscopy, the chemotactic index was calculated. The CD34(+) cells untreated with HMGB1 were used as control. The results indicated that the purity of the isolated CD34(+) cells was more than 98%. The HMGB1 could promote the migration of CD34(+) cells, and the migration effect of HMGB1 on CD34(+) cells in certain concentrations gradually increased along with raise of concentration, the strongest effect was observed in concentration of 100 ng/ml, there was significant difference as compared with control (p < 0.01). Anti-RAGE antibody partially inhibited the migration effect of HMGB1 on CD34(+) cells. It is concluded that the HMGB1 in certain concentration can enhance migration of CD34(+) cells, which may be mediated through RAGE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34
  • Cell Movement / drug effects*
  • Cells, Cultured
  • Female
  • Fetal Blood / cytology
  • Fetal Blood / drug effects*
  • HMGB1 Protein / pharmacology*
  • Humans
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic / metabolism
  • Signal Transduction

Substances

  • Antigens, CD34
  • HMGB1 Protein
  • Receptor for Advanced Glycation End Products
  • Receptors, Immunologic